COGNITION THERAPEUTICS INC
CGTX · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $0.93
- Today’s Low
- $0.76
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.87
- Previous Close
- $0.85
- Volume
- 414.36K
- Market Cap
- $81.48M
- P/E Ratio
- --
- EPS
- $-0.19
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2500 WESTCHESTER AVE., PURCHASE, NY, UNITED STATES, 10577
- Country
- US
- Listing Date
- 2021-10-08
- Fiscal Year End
- December
- Shares Outstanding
- 89.5M
- CIK
- 0001455365
- Website
- cogrx.com
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting age-related degenerative diseases and disorders of the central nervous system and retina. The company is headquartered in Purchase, New York.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$7.73M
2026-03-31
$8.74M
2025-12-31
$13.67M
2025-09-30
$6.31M
Net Income
2026-06-30
-$3.93M
2026-03-31
-$4.57M
2025-12-31
-$3.34M
2025-09-30
-$4.93M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.04
2026-03-31
$-0.05
2025-12-31
$-0.02
2025-09-30
$-0.06
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.87M
2026-03-31
-$4.49M
2025-12-31
-$3.27M
2025-09-30
-$4.86M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $7.73M | $8.74M | $13.67M | $6.31M |
| Net Income | -$3.93M | -$4.57M | -$3.34M | -$4.93M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.04 | $-0.05 | $-0.02 | $-0.06 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.87M | -$4.49M | -$3.27M | -$4.86M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.